These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3108084)

  • 1. Effect of the hormonal contraception on serum reverse triiodothyronine levels.
    Pansini F; Bassi P; Cavallini AR; Ambrosecchia R; Bergamini CM; Meduri P; Bagni B
    Gynecol Obstet Invest; 1987; 23(2):133-4. PubMed ID: 3108084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestagen-dependent effect on some plasma proteins during oral contraception.
    Liukko P; Erkkola R; Bergink EW
    Gynecol Obstet Invest; 1988; 25(2):118-22. PubMed ID: 2967233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
    Mandal B; Maity CR
    Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ACTH-stimulated glucocorticoid hypersecretion on the serum concentrations of thyroxine-binding globulin, thyroxine, triiodothyronine, reverse triiodothyronine and on the TSH-response to TRH.
    Bános C; Takó J; Salamon F; Györgyi S; Czikkely R
    Acta Med Acad Sci Hung; 1979; 36(4):381-94. PubMed ID: 233400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
    Larsson-Cohn U; Wallentin L; Zador G
    Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of free thyroid hormones and their binding proteins in a patient with severe hyperthyroidism (thyroid storm?) and thyroid encephalopathy.
    Colebunders R; Bourdoux P; Bekaert J; Mahler C; Parizel G
    J Endocrinol Invest; 1984 Aug; 7(4):379-81. PubMed ID: 6438222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indicators of arterial blood pressure during hormonal contraception].
    Trutko NS; Dubnitskaia LV; Kuramshina AKh
    Akush Ginekol (Mosk); 1985 Aug; (9):56-7. PubMed ID: 2416229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
    Petersen KR; Skouby SO; Dreisler A; Kühl C
    Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid gland function during childhood and adolescence. Changes in serum TSH, T4, T3, thyroxine-binding globulin, reverse T3 and free T4 and T3 concentrations.
    Parra A; Villalpando S; Junco E; Urquieta B; Alatorre S; García-Bulnes G
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):306-41. PubMed ID: 6769275
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptives and blood coagulation.
    Bonnar J; Sabra AM
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
    Skouby SO; Andersen O; Saurbrey N; Kühl C
    J Clin Endocrinol Metab; 1987 Mar; 64(3):519-23. PubMed ID: 3102539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triphasic pills: variability of endocrine parameters and of sex steroid-binding globulins.
    Pasinetti E; Falsetti L
    Acta Eur Fertil; 1993; 24(2):67-70. PubMed ID: 8171924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A; Rouffy J; Upmalis D; Dain MP
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract]   [Full Text] [Related]  

  • 19. Examinations with Anteovin, a biphasic contraceptive.
    Adám J; Garamvölgyi G
    Ther Hung; 1984; 32(4):176-80. PubMed ID: 6571205
    [No Abstract]   [Full Text] [Related]  

  • 20. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.